← FDA Drug Approvals (Drugs@FDA)

LAMZEDE

BLA · Biologics License Application · Sponsor: CHIESI FARMACEUTICI SPA · Approved 2023-02-16

Drug application

FDA Application #

BLA761278

Application type

Biologics License Application

Brand name

LAMZEDE

Generic name

VELMANASE ALFA-TYCV

Active ingredients

VELMANASE ALFA-TYCV

Dosage form

POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER

Route

—

Marketing status

Prescription

Sponsor

CHIESI FARMACEUTICI SPA

Manufacturer

Chiesi USA, Inc.

First approval

2023-02-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown